K&P Scientific LLC

K&P Scientific LLC

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

K&P Scientific LLC is a privately held, US-based consulting firm founded in 2012 and headquartered in Cambridge, Massachusetts, with a principal office in Forest Park, Illinois. The company operates as a service provider in the drug delivery and ophthalmology sectors, offering specialized consulting in ocular pharmacology, toxicology, and biomarker strategy. Led by Principal Simon Kaja, PhD, a recognized expert in neuropharmacology and ocular drug discovery, the firm bridges the gap between academic research and industry development. It generates revenue by providing tailored project support, CRO selection, and regulatory guidance, positioning itself as a niche expert for clients navigating the complexities of eye drug development.

Ophthalmology

Technology Platform

Integrated knowledge and network platform providing expert consulting in ocular pharmacology, toxicology, and biomarker strategy, leveraging a global network of KOLs and CRO partners.

Opportunities

The growing and innovation-rich ophthalmic therapeutics market creates sustained demand for specialized development expertise.
The firm can capitalize on the influx of biotech startups and investors into ophthalmology who lack internal depth in this complex field.
Expansion of service offerings into adjacent areas like clinical development strategy or regulatory affairs presents a growth path.

Risk Factors

High dependence on the founder's reputation and network (key person risk).
Revenue is subject to cyclicality based on biotech funding and pharma R&D budgets.
Competition from other consultants, larger firms, and CROs offering strategic services.

Competitive Landscape

K&P Scientific competes in the niche of ophthalmic-focused consulting against individual expert consultants, the internal teams of large CROs, and the broader life sciences strategy consulting firms. Its differentiation is its deep, exclusive focus on ophthalmology and the principal's active academic research role, which provides unique, up-to-date scientific credibility.